|Bid||84.35 x 800|
|Ask||84.69 x 800|
|Day's Range||84.01 - 84.74|
|52 Week Range||55.36 - 87.18|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||15.02|
|Forward Dividend & Yield||2.00 (2.37%)|
|Ex-Dividend Date||Apr 22, 2021|
|1y Target Est||N/A|
CVS Health (NYSE: CVS) announced that COVID-19 vaccine appointments for adolescents ages 12 to 15 are now available for scheduling at more than 5,600 CVS Pharmacy locations nationwide, following Food and Drug Administration (FDA) Emergency Use Authorization of the Pfizer-BioNTech vaccine for this age group. Starting tomorrow, May 13, participating CVS Pharmacy locations will begin administering the Pfizer-BioNTech vaccine to this newly eligible population. Parental or legal guardian consent is required, and children must be accompanied by an adult.
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced an upgrade to its CarePass membership program, with prescription delivery within hours now free for eligible CarePass members with an eligible prescription through an expanded partnership with the delivery service Shipt.
In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Sunday, May 9 at 19 select CVS Pharmacy locations throughout New Hampshire.